Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EBITDA / Interest Expenses

Adverum Biotechnlgs EBITDA / Interest Expenses Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EBITDA / Interest Expenses from 2013 to 2014. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Adverum Biotechnlgs EBITDA / Interest Expenses for the quarter ending June 06, 2014 was $-1,107m a 97.51% decrease of -1,079m year over year
  • Adverum Biotechnlgs EBITDA / Interest Expenses for the last 12 months ending March 03, 2015 was $-8,022m a 98.30% decrease of -7,885m year over year
  • Adverum Biotechnlgs Annual EBITDA / Interest Expenses for 2014 was $-1,347m a 97.33% decrease of -1,311m from 2013
  • Adverum Biotechnlgs Annual EBITDA / Interest Expenses for 2013 was $-36m a -530.21% increase of 191m from 2012
  • Adverum Biotechnlgs Annual EBITDA / Interest Expenses for 2012 was $-227m
Other Ratios Metrics:
  • Adverum Biotechnlgs Total Debt / Capital for the quarter ending December 12, 2017 was $0m a 56.92% increase of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Debt / Equity for the quarter ending December 12, 2017 was $0m a 56.98% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM EBITDA / Interest Expenses Data

06/2014$-1,107m
03/2014$-114m
12/2013$-93m
09/2013$-28m
06/2013$-35m
03/2013$-3m

Annual ADVM EBITDA / Interest Expenses Data

2014$-1,347m
2013$-36m
2012$-227m